Boehringer Ingelheim USA Corporation is the U.S. arm of a large pharmaceutical company that works in human and animal health. Its filings show it lobbies Congress and the U.S. Department of Agriculture on farm and animal health issues—like the farm bill, USDA programs, national vaccine stockpiles, and related regulatory processes—and on budget and appropriations matters tied to those programs. It has used Monument Advocacy and reported $200,000 in lobbying through 2026-01-20.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
LILIA MCFARLAND HORDER
The latest disclosures for this client.
MONUMENT ADVOCACY
Q3MONUMENT ADVOCACY
Q2The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
MONUMENT ADVOCACY
mr JOHN WEBER
MONUMENT ADVOCACY
THOMAS ALLEN HAWKS
MONUMENT ADVOCACY
POORVIE PATEL BISHNOI
MONUMENT ADVOCACY
ALEXA FOX
MONUMENT ADVOCACY
MONUMENT ADVOCACY
Q1MONUMENT ADVOCACY
Q4MONUMENT ADVOCACY
Q3MONUMENT ADVOCACY
Q2MONUMENT ADVOCACY
Q1